Coherus BioSciences’ $57.5 Million Follow-On Offering

Latham & Watkins advised Coherus BioSciences, and Davis Polk advised J.P. Morgan Securities LLC and Citigroup Global Markets Inc. on the offering.Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), a…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now